Hybrid Management of Taussig-Bing Syndrome in Neonates: An Innovative Approach to Optimize Outcomes in Complex Congenital Heart Disease
Main Article Content
Abstract
Taussig-Bing syndrome, a rare and complex congenital cardiac malformation characterized by double outlet right ventricle (DORV) with subpulmonary ventricular septal defect (VSD), poses significant challenges for neonatal management. Traditional surgical approaches often involve extensive cardiopulmonary bypass procedures and staged correction, which may increase perioperative risk and prolong recovery. Hybrid strategies combining surgical and interventional cardiology techniques have emerged as an innovative alternative to address the unique anatomical and physiological complexities of this condition.
This article explores the rationale, methodology, and outcomes of hybrid management for neonates with Taussig-Bing syndrome. We detail preoperative planning, intraoperative strategies, and postoperative care, emphasizing the role of multidisciplinary collaboration. The use of stenting, banding techniques, and minimally invasive surgical corrections is evaluated alongside advanced imaging modalities to enhance procedural success. Current evidence and case reports are reviewed to provide a comprehensive overview of this evolving paradigm. Our findings suggest that hybrid management offers a promising avenue for improving survival and reducing morbidity in neonates with Taussig-Bing syndrome, underscoring the need for further research and refinement of these techniques.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Taussig HB, Bing RJ. Complete transposition of the aorta and a levoposition of the pulmonary artery; clinical, physiological, and pathological findings. Am Heart J 1949;37(4):551–9.
II. Dunn PM. Dr. Helen Taussig (1898–1986): pioneering American paediatric cardiologist. Arch Dis Child Fetal Neonatal Ed 2008;93(1):F74-6.
III. Weisse AB. Heart to heart. The twentieth-century battle against cardiac disease. An oral history. New Brunswick (NJ): Rutgers University Press, 2002.
IV. Engle MA. Dr. Helen B. Taussig, the tetralogy of Fallot, and the growth of pediatric cardiac services in the United States. Johns Hopkins Med J 1977;140(4):147–50.
V. Neill CA. Dr. Helen Brooke Taussig May 24, 1898–May 21, 1986. International cardiologist. Int J Cardiol 1987;14(2):255–61.
VI. Blalock A, Taussig HB. Landmark article May 19, 1945: The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA 1984:251(16):2123–38.
VII. Taussig HB. Congenital malformations of the heart. 2nd ed. Cambridge: published for the Commonwealth Fund by Harvard University Press; 1960.
VIII. Collins C. Royal College of Nursing leads national audit of the management of venous leg ulcers. J Tissue Viability 2006; 16(1):6–7.
IX. Taussig HB, Crawford H, Pelargonio S, Zacharioudakis S. Ten to thirteen year follow-up on patients after a Blalock-Taussig operation. Circulation 1962;25:630–4.
X. Bing RJ. Richard John Bing, MD: a conversation with John Willis Hurst, MD. Am J Cardiol 2000;86(1):72–9.
XI. Bing RJ. An investigator's journey in cardiology. JAMA 1992; 267(7):969–72.]
XII. Bing R. The perfusion of whole organs in the Lindbergh apparatus with fluids containing hemocyanin as respiratory pigment. Science 1938;87(2268):554–5.
XIII. Bing RJ. The Johns Hopkins: the Blalock-Taussig era. Perspect Biol Med 1988;32(1):85–90.
XIV. Van Praagh R. What is the Taussig-Bing malformation? Circulation 1968;38(3):445–9.
XV. Stellin G, Zuberbuhler JR, Anderson RH, Siewers RD. The surgical anatomy of the Taussig-Bing malformation. J Thorac Cardiovasc Surg 1987;93(4):560–9.
XVI. Yacoub MH, Radley-Smith R. Anatomic correction of the Taussig-Bing anomaly. J Thorac Cardiovasc Surg 1984;88(3): 380–8.